These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 6492268

  • 1. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B, Sarig S, Azoury R, Wax Y, Hirsch D, Perlberg S, Many M.
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [Abstract] [Full Text] [Related]

  • 2. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B, Sarig S, Azoury R, Orda S, Boichis H, Wax Y, Many M.
    Eur Urol; 1985 Nov; 11(1):40-3. PubMed ID: 3987747
    [Abstract] [Full Text] [Related]

  • 3. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Nov; 53():265-71. PubMed ID: 6938003
    [Abstract] [Full Text] [Related]

  • 4. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J, Zechner O.
    Eur Urol; 1988 Nov; 15(3-4):227-9. PubMed ID: 3215256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperuricosuric calcium nephrolithiasis.
    Sorensen CM, Chandhoke PS.
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):915-25. PubMed ID: 12474638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyperuricosuric calcium urolithiasis.
    Moe OW, Xu LHR.
    J Nephrol; 2018 Apr; 31(2):189-196. PubMed ID: 29368300
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC, Monforte MF, Briceño A.
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Nov; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Uric acid saturation in calcium nephrolithiasis.
    Coe FL, Strauss AL, Tembe V, Le Dun S.
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [Abstract] [Full Text] [Related]

  • 19. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D, Kalaiselvi P, Varalakshmi P.
    Nephron Physiol; 2004 May; 97(1):p23-30. PubMed ID: 15153748
    [Abstract] [Full Text] [Related]

  • 20. The uric acid: cystine correlation in the urine of recurrent calcium oxalate stone-formers and healthy controls.
    Leskovar P, Hartung R, Kratzer M.
    Adv Exp Med Biol; 1980 May; 122A():115-9. PubMed ID: 7191616
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.